老年人慢性肾脏病：初级保健提供者面临的挑战和机遇。
Chronic kidney disease in older adults: challenges and opportunities for the primary care provider.
机构信息
Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
出版信息
BMC Prim Care. 2024 Nov 1;25(1):388. doi: 10.1186/s12875-024-02638-4.
Abstract
Kidney disease and its comorbidities disproportionately affect older persons. Kidney disease modifying therapy is underutilized in older adults, as guidelines lack consensus on approaching diagnosis and treatment in older adults. This review aims to highlight the challenges presented by, and opportunities for, identifying and treating CKD in older adults.
摘要
肾脏疾病及其合并症在老年人中不成比例地发生。肾脏疾病的治疗方法在老年人中未得到充分利用，因为指南在老年人的诊断和治疗方法上缺乏共识。本综述旨在强调在老年人中识别和治疗 CKD 所面临的挑战和机遇。
相似文献
1
Chronic kidney disease in older adults: challenges and opportunities for the primary care provider.
BMC Prim Care. 2024 Nov 1;25(1):388. doi: 10.1186/s12875-024-02638-4.
2
Integrating guidelines, CKD, multimorbidity, and older adults.
Am J Kidney Dis. 2015 Mar;65(3):494-501. doi: 10.1053/j.ajkd.2014.09.024. Epub 2014 Dec 4.
3
[What do we know about chronic kidney disease at the beginning of the 21st century?].
Acta Med Croatica. 2014 Apr;68(2):75-7.
4
Barriers and enablers to detection and management of chronic kidney disease in primary healthcare: a systematic review.
BMC Nephrol. 2020 Mar 12;21(1):83. doi: 10.1186/s12882-020-01731-x.
5
Mild chronic kidney disease and functional impairment in community-dwelling older adults.
Age Ageing. 2013 Jul;42(4):488-94. doi: 10.1093/ageing/aft007. Epub 2013 Feb 24.
6
Development and Validation of the Rating of CKD Knowledge Among Older Adults (Know-CKD) With Kidney Failure.
Am J Kidney Dis. 2024 May;83(5):569-577. doi: 10.1053/j.ajkd.2023.09.024. Epub 2023 Dec 7.
7
Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data.
BMC Nephrol. 2013 Jan 25;14:24. doi: 10.1186/1471-2369-14-24.
8
A population-based cohort study defines prognoses in severe chronic kidney disease.
Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.
9
Primary care physicians' perceived barriers, facilitators and strategies to enhance conservative care for older adults with chronic kidney disease: a qualitative descriptive study.
Nephrol Dial Transplant. 2016 Nov;31(11):1864-1870. doi: 10.1093/ndt/gfv408. Epub 2015 Dec 17.
10
Epidemiology and Public Health Concerns of CKD in Older Adults.
Adv Chronic Kidney Dis. 2016 Jan;23(1):8-11. doi: 10.1053/j.ackd.2015.10.001.
本文引用的文献
1
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.
J Gen Intern Med. 2024 May;39(6):921-930. doi: 10.1007/s11606-023-08397-9. Epub 2023 Dec 14.
2
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
3
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
J Gerontol A Biol Sci Med Sci. 2024 Feb 1;79(2). doi: 10.1093/gerona/glad181.
4
Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease.
JAMA Netw Open. 2023 Jul 3;6(7):e2326230. doi: 10.1001/jamanetworkopen.2023.26230.
5
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7.
6
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2023 Mar;81(3 Suppl1):A8-A11. doi: 10.1053/j.ajkd.2022.12.001.
7
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.
Am J Kidney Dis. 2023 Jul;82(1):53-62.e1. doi: 10.1053/j.ajkd.2022.11.017. Epub 2023 Jan 23.
8
Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study.
BMC Prim Care. 2022 Dec 7;23(1):317. doi: 10.1186/s12875-022-01928-z.
9
Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease.
J Gen Intern Med. 2023 May;38(7):1599-1605. doi: 10.1007/s11606-022-07863-0. Epub 2022 Nov 9.
10
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
Zotero 插件